G-CSF primed bone marrow in HLA-haploidentical transplantation using post-transplantation cyclophosphamide (PTCY) could promote tolerance and further reduce risk of GVHD

被引：0
|
作者：
Durakovic, Nadira [1 ,2 ]
Peric, Zinaida [1 ,2 ]
Desnica, Lana [2 ]
Serventi-Seiwerth, Ranka [2 ]
Mikulic, Mirta [2 ]
Melamed, Brian [3 ]
Ostojic, Alen [2 ]
Pulanic, Drazen [1 ,2 ]
Roncevic, Pavle [2 ]
Grubic, Zorana [2 ]
Vrhovac, Radovan [1 ,2 ]
机构：
[1] Univ Zagreb, Zagreb, Croatia
[2] UHC Zagreb, Zagreb, Croatia
[3] Gen Hosp Bjelovar, Bjelovar, Croatia
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P673
引用
收藏
页码：571 / 572
页数：2
相关论文
共 50 条
  • [1] Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
    Luznik, Leo
    O'Donnell, Paul V.
    Fuchs, Ephraim J.
    [J]. SEMINARS IN ONCOLOGY, 2012, 39 (06) : 683 - 693
  • [2] Use of G-CSF Mobilized Bone Marrow Grafts in HLA-haploidentical Bone Marrow Transplantation (BMT) with Post-transplantation Cyclophosphamide (PT-Cy) Decreases Risk of Severe Acute GVHD
    Durakovic, Nadira
    Peric, Zinaida
    Desnica, Lana
    Grubic, Zorana
    Romic, Lucija
    Serventi-Seiwerth, Ranka
    Vrhovac, Radovan
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 707 - 708
  • [3] Use of G-CSF mobilized bone marrow grafts in HLA-haploidentical related bone marrow transplantation (BMT) with post-transplantation cyclophosphamide (PT-CY)
    Nadira, D.
    Brian, M. J.
    Zinaida, P.
    Lana, D.
    Alen, O.
    Zorana, G.
    Ranka, S. S.
    Radovan, V.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S147 - S148
  • [4] Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
    Munchel, Ashley
    Kesserwan, Chimen
    Symons, Heather J.
    Luznik, Leo
    Kasamon, Yvette L.
    Jones, Richard J.
    Fuchs, Ephraim J.
    [J]. PEDIATRIC REPORTS, 2011, 3 : 43 - 47
  • [5] Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation
    McAdams, Meredith J.
    Hyder, Mustafa
    Dimitrova, Dimana
    Sadler, Jennifer L.
    McKeown, Christi
    Steinberg, Seth M.
    Chai, Amy
    Napier, Scott
    Stokes, Anita
    Sponaugle, Jennifer
    Hughes, Thomas E.
    RiCha, Nu
    Cuellar-Rodriguez, Jennifer
    Walker, Melissa
    Gress, Ronald E.
    Kanakry, Jennifer A.
    Kanakry, Christopher G.
    [J]. BLOOD, 2021, 138
  • [6] HLA-haploidentical bone marrow transplantation with high-dose post-transplantation cyclophosphamide (Cy)
    Busca, A.
    Bruno, B.
    Giaccone, L.
    Festuccia, M.
    Testa, F.
    Allione, B.
    D'Ardia, S.
    Dellacasa, C.
    Pecoraro, C.
    Marmont, F.
    Falda, M.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S185 - S185
  • [7] A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform
    Mayumi, Hisanori
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
    Fuchs, E. J.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S31 - S36
  • [9] HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
    E J Fuchs
    [J]. Bone Marrow Transplantation, 2015, 50 : S31 - S36
  • [10] Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide
    Munchel, Ashley T.
    Kasamon, Yvette L.
    Fuchs, Ephraim J.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2011, 24 (03) : 359 - 368
12345